Last reviewed · How we verify
China International Neuroscience Institution — Portfolio Competitive Intelligence Brief
5 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Propofol half | Propofol half | marketed | ||||
| 2% Sevoflurane | 2% Sevoflurane | marketed | ||||
| Preemptive Analgesia Of Dexmedetomidine | Preemptive Analgesia Of Dexmedetomidine | marketed | Alpha-2 adrenergic agonist | Alpha-2 adrenergic receptor | Anesthesia and Pain Management | |
| Preemptive Dexmedetomidine injection | Preemptive Dexmedetomidine injection | marketed | Alpha-2 adrenergic receptor agonist | Alpha-2 adrenergic receptor | Anesthesia and Perioperative Medicine | |
| hydroxyethl starch | hydroxyethl starch | marketed | Synthetic colloid / Volume expander | Critical Care / Anesthesia |
Therapeutic area mix
- Anesthesia and Pain Management · 1
- Anesthesia and Perioperative Medicine · 1
- Critical Care / Anesthesia · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- American University of Beirut Medical Center · 2 shared drug classes
- Tang-Du Hospital · 2 shared drug classes
- Icahn School of Medicine at Mount Sinai · 2 shared drug classes
- Allergan · 1 shared drug class
- Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
- Derm Research, PLLC · 1 shared drug class
- Azienda Ospedaliera di Padova · 1 shared drug class
- Eye & ENT Hospital of Fudan University · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for China International Neuroscience Institution:
- China International Neuroscience Institution pipeline updates — RSS
- China International Neuroscience Institution pipeline updates — Atom
- China International Neuroscience Institution pipeline updates — JSON
Cite this brief
Drug Landscape (2026). China International Neuroscience Institution — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/china-international-neuroscience-institution. Accessed 2026-05-17.